NO177187C - Analogifremgangsmåte for fremstilling av terapautisk aktive N,N'-bis(alkoksy-alkyl)-pyridin-2,4-dikarboksylsyrediamider - Google Patents

Analogifremgangsmåte for fremstilling av terapautisk aktive N,N'-bis(alkoksy-alkyl)-pyridin-2,4-dikarboksylsyrediamider

Info

Publication number
NO177187C
NO177187C NO903235A NO903235A NO177187C NO 177187 C NO177187 C NO 177187C NO 903235 A NO903235 A NO 903235A NO 903235 A NO903235 A NO 903235A NO 177187 C NO177187 C NO 177187C
Authority
NO
Norway
Prior art keywords
pyridine
bis
dicarboxylic acid
alkyl
alkoxy
Prior art date
Application number
NO903235A
Other languages
English (en)
Other versions
NO177187B (no
NO903235L (no
NO903235D0 (no
Inventor
Ekkehard Baader
Martin Bickel
Volkmar Gunzler-Pukall
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO903235D0 publication Critical patent/NO903235D0/no
Publication of NO903235L publication Critical patent/NO903235L/no
Publication of NO177187B publication Critical patent/NO177187B/no
Publication of NO177187C publication Critical patent/NO177187C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO903235A 1989-07-20 1990-07-19 Analogifremgangsmåte for fremstilling av terapautisk aktive N,N'-bis(alkoksy-alkyl)-pyridin-2,4-dikarboksylsyrediamider NO177187C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3924093A DE3924093A1 (de) 1989-07-20 1989-07-20 N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung

Publications (4)

Publication Number Publication Date
NO903235D0 NO903235D0 (no) 1990-07-19
NO903235L NO903235L (no) 1991-01-21
NO177187B NO177187B (no) 1995-04-24
NO177187C true NO177187C (no) 1995-08-02

Family

ID=6385494

Family Applications (1)

Application Number Title Priority Date Filing Date
NO903235A NO177187C (no) 1989-07-20 1990-07-19 Analogifremgangsmåte for fremstilling av terapautisk aktive N,N'-bis(alkoksy-alkyl)-pyridin-2,4-dikarboksylsyrediamider

Country Status (26)

Country Link
EP (1) EP0409119B1 (no)
JP (1) JPH0776213B2 (no)
KR (1) KR0181945B1 (no)
AT (1) ATE104280T1 (no)
AU (1) AU624978B2 (no)
CA (1) CA2021529C (no)
CY (1) CY1997A (no)
CZ (1) CZ280129B6 (no)
DD (1) DD300429A5 (no)
DE (2) DE3924093A1 (no)
DK (1) DK0409119T3 (no)
ES (1) ES2052112T3 (no)
FI (1) FI94630C (no)
HU (1) HU218274B (no)
IE (1) IE64438B1 (no)
IL (1) IL95121A (no)
LT (1) LT3798B (no)
LV (1) LV10430B (no)
NO (1) NO177187C (no)
NZ (1) NZ234563A (no)
PL (1) PL166307B1 (no)
PT (1) PT94779B (no)
RU (1) RU1836350C (no)
SK (1) SK279199B6 (no)
UA (1) UA19056A (no)
ZA (1) ZA905680B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3707429A1 (de) * 1987-03-07 1988-09-15 Hoechst Ag Substituierte pyridin-2,4-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
EP0353668B1 (de) * 1988-08-04 1994-10-19 Hoechst Aktiengesellschaft Verbessertes Verfahren zur Herstellung von N,N-Bis(alkoxyalkyl)-pyridin -2,4-dicarbonsäurediamiden
DE4020570A1 (de) 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung
DE4030999A1 (de) * 1990-10-01 1992-04-09 Hoechst Ag 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
YU9492A (sh) * 1991-02-05 1995-03-27 Hoechst Ag. 2,4- i 2,5-bis-tetrazolilni piridini i postupak za njihovo dobijanje
TW199147B (no) * 1991-03-18 1993-02-01 Hoechst Ag
EP0541042A1 (de) * 1991-11-05 1993-05-12 Hoechst Aktiengesellschaft Pyridin-2,4- und 2,5-dicarbonsäureamide und deren Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
TW222585B (no) * 1992-09-11 1994-04-21 Hoechst Ag
DOP2002000332A (es) 2001-02-14 2002-08-30 Warner Lambert Co Inhibidores de piridina de metaloproteinasas de la matriz

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432094A1 (de) 1984-08-31 1986-03-06 Hoechst Ag, 6230 Frankfurt Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
DE3703962A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3703963A1 (de) 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
EP0353668B1 (de) * 1988-08-04 1994-10-19 Hoechst Aktiengesellschaft Verbessertes Verfahren zur Herstellung von N,N-Bis(alkoxyalkyl)-pyridin -2,4-dicarbonsäurediamiden
DE3828140A1 (de) 1988-08-19 1990-03-01 Hoechst Ag Verbessertes verfahren zur herstellung von n,n'-bis(alkoxyalkyl)-pyridin-2,4-dicarbonsaeurediamiden sowie verwendung dieser verbindungen zur herstellung oralverabreichbarer arzneimittel
DE3826471A1 (de) 1988-08-04 1990-02-22 Hoechst Ag Verbessertes verfahren zur herstellung von n,n'-bis(alkoxyalkyl)-pyridin-2,4-dicarbonsaeurediamiden

Also Published As

Publication number Publication date
IL95121A0 (en) 1991-06-10
CZ357690A3 (en) 1995-06-14
KR0181945B1 (ko) 1999-05-01
JPH0776213B2 (ja) 1995-08-16
FI903624A0 (fi) 1990-07-18
CA2021529A1 (en) 1991-01-21
KR910002799A (ko) 1991-02-26
ES2052112T3 (es) 1994-07-01
PL166307B1 (pl) 1995-05-31
PT94779A (pt) 1991-03-20
NO177187B (no) 1995-04-24
ATE104280T1 (de) 1994-04-15
IE902642A1 (en) 1991-02-27
CY1997A (en) 1997-09-05
LTIP1462A (en) 1995-05-25
NO903235L (no) 1991-01-21
LV10430A (lv) 1995-02-20
PL286132A1 (en) 1991-07-29
DK0409119T3 (da) 1994-08-08
DE59005328D1 (de) 1994-05-19
HU904549D0 (en) 1990-12-28
EP0409119A1 (de) 1991-01-23
NZ234563A (en) 1992-12-23
FI94630C (fi) 1995-10-10
CA2021529C (en) 1997-12-30
DE3924093A1 (de) 1991-02-07
DD300429A5 (de) 1992-06-11
AU624978B2 (en) 1992-06-25
LT3798B (en) 1996-03-25
HUT54653A (en) 1991-03-28
ZA905680B (en) 1991-04-24
RU1836350C (ru) 1993-08-23
IE64438B1 (en) 1995-08-09
IL95121A (en) 1994-08-26
SK357690A3 (en) 1998-07-08
PT94779B (pt) 1997-04-30
CZ280129B6 (cs) 1995-11-15
EP0409119B1 (de) 1994-04-13
NO903235D0 (no) 1990-07-19
JPH0358973A (ja) 1991-03-14
LV10430B (en) 1996-02-20
AU5914490A (en) 1991-01-24
HU218274B (en) 2000-07-28
FI94630B (fi) 1995-06-30
UA19056A (uk) 1997-12-25
SK279199B6 (sk) 1998-07-08

Similar Documents

Publication Publication Date Title
HUT58322A (en) Process for producing new n-(3-hydroxy-4-piperidinyl)-dihydro-benzofurane-, -dihydro-2h-penzopyrane- and -dihydro-benzodioxine-carboxamide derivatives and pharmaceutical compositions containing them
ES2000185A6 (es) Procedimiento para preparar derivados de acidos piridoncaboxilicos
HUT61004A (en) Process for producing quinoxaline derivatives and pharmaceutical compositions comprising such compounds as active ingredient
ATE411309T1 (de) Pyridonkarbonsaüre derivate und deren verwendung als antibakterielle wirkstoffe
NO177187C (no) Analogifremgangsmåte for fremstilling av terapautisk aktive N,N'-bis(alkoksy-alkyl)-pyridin-2,4-dikarboksylsyrediamider
NO161619C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive substituerte 5,11-dihydro-6-dibenz(b,e)-azepin-6-on-derivater.
ES2001703A6 (es) Procedimiento para la preparracion de derrrivados de acidos 2-(2-imidazolin -2-il)- piridin -3- carboxilicos.
ATE32221T1 (de) 3 n-substituierte 3,4-dihydropyrimidinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
NO913391L (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
CA2014062A1 (en) Pyridine derivatives
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
ES2082882T3 (es) Procedimiento para la fabricacion de derivados de acidos-3-amino-2-(het)aroil-acrilicos.
ATE158576T1 (de) Alpha-aryl-alpha-hydroxy-beta- imidazolinylpropionsäureamide
ATE78154T1 (de) Salz von 6-(1-piperidinyl-)2,4-diaminopyrimidin-3-oxyd und acetylaminoessigsaeure deren herstellung und deren dermatokosmetische verwendung.
MX9201156A (es) Diamidas mixtas de acidos piridina -2,4- y 2,5 dicarboxilicos, procedimiento para su preparacion, utilizacion de las mismas asi como medicamentos a base de estos compuestos.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2003